Is Ocugen Stock a Buy Now?
25/2 14:12
Ocugen (NASDAQ: OCGN) got some positive news last week as the Food and Drug Administration (FDA) lifted the clinical hold on its investigational new drug application (IND) for Covaxin, also known as BBV152. The stock jumped in after-hours trading on the news, though it has since...